Literature DB >> 31562204

DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas.

Andreas von Deimling1, Uta E Flucke2, Marije E Weidema3, Ellen van de Geer4, Christian Koelsche5, Ingrid M E Desar6, Patrick Kemmeren4, Melissa H S Hillebrandt-Roeffen6, Vincent K Y Ho, Winette T A van der Graaf6,7, Yvonne M H Versleijen-Jonkers6.   

Abstract

PURPOSE: DNA methylation profiling has previously uncovered biologically and clinically meaningful subgroups within many tumor types, but was not yet performed in angiosarcoma. Angiosarcoma is a rare sarcoma with very heterogeneous clinical presentations, which may be based on differences in biological background. In this exploratory study, DNA methylation profiling of 36 primary angiosarcoma samples from visceral, deep soft tissue, radiation-induced, and UV-induced localizations was performed. EXPERIMENTAL
DESIGN: Primary angiosarcoma formalin-fixed paraffin-embedded samples from visceral, soft tissue, radiation-induced, and UV-induced origin were collected from a nationwide search for angiosarcoma in the Netherlands. DNA was extracted for methylation profiling with the Illumina Infinium MethylationEPIC array. Quality control assessment and unsupervised hierarchical clustering were performed. Copy-number profiles were generated and analyzed for chromosomal stability. Clinical data were obtained from the Netherlands Cancer Registry.
RESULTS: DNA methylation profiling by unsupervised hierarchical clustering of 36 angiosarcoma samples (6 visceral, 5 soft tissue, 14 radiation-induced, 11 UV-induced) revealed two main clusters (A and B), which were divided into four subclusters. The clusters largely corresponded with clinical subtypes, showing enrichment of UV-induced cases in cluster A1 and radiation-induced cases in cluster A2. Visceral and soft tissue cases almost exclusively fell into cluster B. Cluster A showed significantly increased chromosomal instability and better overall survival (22 vs. 6 months, P = 0.046) compared with cluster B.
CONCLUSIONS: In this novel methylation profiling study, we demonstrated for the first time four different angiosarcoma clusters. These clusters correlated with clinical subtype, overall survival, and chromosomal stability. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31562204     DOI: 10.1158/1078-0432.CCR-19-2180

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  13 in total

Review 1.  Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis.

Authors:  Isidro Machado; Francisco Giner; Javier Lavernia; Julia Cruz; Víctor Traves; Celia Requena; Beatriz Llombart; José Antonio López-Guerrero; Antonio Llombart-Bosch
Journal:  Histol Histopathol       Date:  2020-09-04       Impact factor: 2.303

Review 2.  Immune checkpoint inhibitor resistance in soft tissue sarcoma.

Authors:  Vanessa Eulo; Brian A Van Tine
Journal:  Cancer Drug Resist       Date:  2022-04-06

3.  Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.

Authors:  Jason Yongsheng Chan; Jing Quan Lim; Joe Yeong; Vinod Ravi; Peiyong Guan; Arnoud Boot; Timothy Kwang Yong Tay; Sathiyamoorthy Selvarajan; Nur Diyana Md Nasir; Jie Hua Loh; Choon Kiat Ong; Dachuan Huang; Jing Tan; Zhimei Li; Cedric Chuan-Young Ng; Thuan Tong Tan; Mikio Masuzawa; Ken Wing-Kin Sung; Mohamad Farid; Richard Hong Hui Quek; Ngian Chye Tan; Melissa Ching Ching Teo; Steven George Rozen; Patrick Tan; Andrew Futreal; Bin Tean Teh; Khee Chee Soo
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 4.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

5.  Sarcoma classification by DNA methylation profiling.

Authors:  Christian Koelsche; Daniel Schrimpf; Damian Stichel; Martin Sill; Felix Sahm; David E Reuss; Mirjam Blattner; Barbara Worst; Christoph E Heilig; Katja Beck; Peter Horak; Simon Kreutzfeldt; Elke Paff; Sebastian Stark; Pascal Johann; Florian Selt; Jonas Ecker; Dominik Sturm; Kristian W Pajtler; Annekathrin Reinhardt; Annika K Wefers; Philipp Sievers; Azadeh Ebrahimi; Abigail Suwala; Francisco Fernández-Klett; Belén Casalini; Andrey Korshunov; Volker Hovestadt; Felix K F Kommoss; Mark Kriegsmann; Matthias Schick; Melanie Bewerunge-Hudler; Till Milde; Olaf Witt; Andreas E Kulozik; Marcel Kool; Laura Romero-Pérez; Thomas G P Grünewald; Thomas Kirchner; Wolfgang Wick; Michael Platten; Andreas Unterberg; Matthias Uhl; Amir Abdollahi; Jürgen Debus; Burkhard Lehner; Christian Thomas; Martin Hasselblatt; Werner Paulus; Christian Hartmann; Ori Staszewski; Marco Prinz; Jürgen Hench; Stephan Frank; Yvonne M H Versleijen-Jonkers; Marije E Weidema; Thomas Mentzel; Klaus Griewank; Enrique de Álava; Juan Díaz Martín; Miguel A Idoate Gastearena; Kenneth Tou-En Chang; Sharon Yin Yee Low; Adrian Cuevas-Bourdier; Michel Mittelbronn; Martin Mynarek; Stefan Rutkowski; Ulrich Schüller; Viktor F Mautner; Jens Schittenhelm; Jonathan Serrano; Matija Snuderl; Reinhard Büttner; Thomas Klingebiel; Rolf Buslei; Manfred Gessler; Pieter Wesseling; Winand N M Dinjens; Sebastian Brandner; Zane Jaunmuktane; Iben Lyskjær; Peter Schirmacher; Albrecht Stenzinger; Benedikt Brors; Hanno Glimm; Christoph Heining; Oscar M Tirado; Miguel Sáinz-Jaspeado; Jaume Mora; Javier Alonso; Xavier Garcia Del Muro; Sebastian Moran; Manel Esteller; Jamal K Benhamida; Marc Ladanyi; Eva Wardelmann; Cristina Antonescu; Adrienne Flanagan; Uta Dirksen; Peter Hohenberger; Daniel Baumhoer; Wolfgang Hartmann; Christian Vokuhl; Uta Flucke; Iver Petersen; Gunhild Mechtersheimer; David Capper; David T W Jones; Stefan Fröhling; Stefan M Pfister; Andreas von Deimling
Journal:  Nat Commun       Date:  2021-01-21       Impact factor: 17.694

6.  Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.

Authors:  Gerwin Heller; Thomas Brodowicz; Angelika M Starzer; Anna S Berghoff; Rainer Hamacher; Erwin Tomasich; Katharina Feldmann; Teresa Hatziioannou; Stefan Traint; Wolfgang Lamm; Iris M Noebauer-Huhmann; Julia Furtner; Leonhard Müllauer; Gabriele Amann; Sebastian Bauer; Hans-Ulrich Schildhaus; Matthias Preusser
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

7.  PARP inhibition in UV-associated angiosarcoma preclinical models.

Authors:  Marije E Weidema; Ingrid M E Desar; Melissa H S Hillebrandt-Roeffen; Anke E M van Erp; Mikio Masuzawa; Uta E Flucke; Winette T A van der Graaf; Yvonne M H Versleijen-Jonkers
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-03       Impact factor: 4.553

8.  DNA methylation-based classification of malformations of cortical development in the human brain.

Authors:  Samir Jabari; Katja Kobow; Andreas von Deimling; Ingmar Blümcke; Tom Pieper; Till Hartlieb; Manfred Kudernatsch; Tilman Polster; Christian G Bien; Thilo Kalbhenn; Matthias Simon; Hajo Hamer; Karl Rössler; Martha Feucht; Angelika Mühlebner; Imad Najm; José Eduardo Peixoto-Santos; Antonio Gil-Nagel; Rafael Toledano Delgado; Angel Aledo-Serrano; Yanghao Hou; Roland Coras
Journal:  Acta Neuropathol       Date:  2021-11-19       Impact factor: 17.088

9.  Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2-Cre mice.

Authors:  Jason A Hanna; Casey G Langdon; Matthew R Garcia; Annaleigh Benton; Nadia A Lanman; David Finkelstein; Jerold E Rehg; Mark E Hatley
Journal:  J Pathol       Date:  2022-02-15       Impact factor: 9.883

10.  Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature.

Authors:  Andreas von Deimling; Gunhild Mechtersheimer; Christian Koelsche; Jamal K Benhamida; Felix K F Kommoss; Damian Stichel; David T W Jones; Stefan M Pfister; Christoph E Heilig; Stefan Fröhling; Albrecht Stenzinger; Rolf Buslei; Thomas Mentzel; Daniel Baumhoer; Marc Ladanyi; Cristina R Antonescu; Uta Flucke; Joost van Gorp; Beata Bode-Lesniewska
Journal:  Mod Pathol       Date:  2021-07-26       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.